0001447028-24-000026.txt : 20240205
0001447028-24-000026.hdr.sgml : 20240205
20240205195425
ACCESSION NUMBER: 0001447028-24-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sofia Michael J.
CENTRAL INDEX KEY: 0001635324
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 24597685
MAIL ADDRESS:
STREET 1: C/O ARBUTUS BIOPHARMA CORP.
STREET 2: SUITE 100, 8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 980597776
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 701 VETERANS CIRCLE
CITY: WARMINSTER
STATE: PA
ZIP: 18974
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 701 VETERANS CIRCLE
CITY: WARMINSTER
STATE: PA
ZIP: 18974
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
4
1
wk-form4_1707180851.xml
FORM 4
X0508
4
2024-02-01
0
0001447028
Arbutus Biopharma Corp
ABUS
0001635324
Sofia Michael J.
C/O ARBUTUS BIOPHARMA CORPORATION
701 VETERANS CIRCLE
WARMINSTER
PA
18974
0
1
0
0
Chief Scientific Officer
1
Common Shares
2024-02-01
4
A
0
109500
0
A
1495103
D
Common Shares
2024-02-02
4
S
0
9982
2.3125
D
1485121
D
Common Shares
167162
I
By Trust
Stock Option (Right to Buy)
2.40
2024-02-01
4
A
0
437800
0
A
2034-02-01
Common Shares
437800
437800
D
Represents the grant of restricted stock units ("RSUs"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.
Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 5, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of a previous grant of restricted stock units.
These shares are owned by the Irrevocable Deed of Trust of Michael J. Sofia dated July 6, 2020 (the "Trust"). The Reporting Person's wife and adult children are both the Trustees and the beneficiaries of the Trust. The Reporting Person disclaims beneficial ownership of the shares owned by the Trust and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.
This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.
/s/ David C. Hastings as attorney-in-fact for Michael J. Sofia
2024-02-05